Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Barron

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Lancet. Rheumatology|May 17, 2025
Why is progressive ILD in systemic sclerosis so difficult to predict?Kathleen Morrisroe, Murray Barron
Rheumatic Diseases Clinics of North America|April 7, 2023
Health Care Utilization: What Is the Cost of Caring for Scleroderma?Kathleen Morrisroe, Nora Sandorfi, Murray Barron
Seminars in Arthritis and Rheumatism|September 20, 2025
The prognostic importance of worsening dyspnoea in systemic sclerosis related interstitial lung diseaseKathleen Morrisroe, Dylan Hansen, Wendy Stevens, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Lancet. Rheumatology|May 17, 2025
Why is progressive ILD in systemic sclerosis so difficult to predict?Kathleen Morrisroe, Murray Barron
Rheumatic Diseases Clinics of North America|April 7, 2023
Health Care Utilization: What Is the Cost of Caring for Scleroderma?Kathleen Morrisroe, Nora Sandorfi, Murray Barron
Seminars in Arthritis and Rheumatism|September 20, 2025
The prognostic importance of worsening dyspnoea in systemic sclerosis related interstitial lung diseaseKathleen Morrisroe, Dylan Hansen, Wendy Stevens, et al.
Pageof 1